| |
Second Intervention
|
|---|
|
First Intervention
|
vs. Control
|
vs. Placebo
|
vs. Pharm
|
Vs. Non-Pharm1 from same category
|
vs. Non-Pharm1 from different category
|
Total
|
|---|
|
Pharmacological
|
4027 (18%)
|
4321 (19%)
|
5571 (25%)
|
n/a
|
186 (<1%)
|
14105 (63%)
|
|
Vaccines
|
95 (<1%)
|
113 (<1%)
|
0 (0%)
|
49 (<1%)
|
0 (0%)
|
257 (1%)
|
|
Surgical
|
241 (1%)
|
2 (<1%)
|
29 (<1%)
|
1204 (5%)
|
86 (<1%)
|
1562 (7%)
|
|
Medical devices
|
706 (3%)
|
50 (<1%)
|
82 (<1%)
|
941 (4%)
|
159 (<1%)
|
1938 (9%)
|
|
Cellular and gene
|
29 (<1%)
|
6 (<1%)
|
0 (0%)
|
57 (<1%)
|
7 (<1%)
|
99 (<1%)
|
|
Radiotherapy
|
124 (<1%)
|
65 (<1%)
|
3 (<1%)
|
56 (<1%)
|
63 (<1%)
|
311 (1%)
|
|
Physical
|
318 (1%)
|
10 (<1%)
|
8 (<1%)
|
72 (<1%)
|
39 (<1%)
|
447 (2%)
|
|
Educational
|
303 (1%)
|
4 (<1%)
|
1 (<1%)
|
34 (<1%)
|
27 (<1%)
|
369 (2%)
|
|
Behavioural
|
380 (2%)
|
7 (<1%)
|
3 (<1%)
|
165 (<1%)
|
14 (<1%)
|
569 (3%)
|
|
Screening
|
17 (<1%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
0 (0%)
|
17 (<1%)
|
|
Complementary
|
216 (1%)
|
104 (<1%)
|
41 (<1%)
|
8 (<1%)
|
19 (<1%)
|
388 (2%)
|
|
Psychological
|
379 (2%)
|
1 (<1%)
|
6 (<1%)
|
116 (<1%)
|
44 (<1%)
|
546 (2%)
|
|
Resources and infrastructure
|
506 (2%)
|
0 (0%)
|
14 (<1%)
|
52 (<1%)
|
33 (<1%)
|
605 (3%)
|
|
Complex
|
505 (2%)
|
36 (<1%)
|
43 (<1%)
|
200 (<1%)
|
154 (<1%)
|
938 (4%)
|
|
Other
|
188 (1%)
|
44 (<1%)
|
8 (<1%)
|
51 (<1%)
|
11 (<1%)
|
302 (1%)
|
|
Total
|
8034 (36%)
|
4763 (21%)
|
5809 (26%)
|
3005 (13%)
|
842 (4%)
|
22453
|
-
1Non-Pharm = all intervention categories as listed for the First intervention, other than Pharmacological
- n/a = not applicable
